Airway Disease: Clinical Trials

2 trials for Airway Disease, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 enrolling by invitation, 1 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Enrolling by invitation 1, Unknown 1

Follow Airway Disease: new trials by email Literature Review of Airway Disease trials Research Report on Airway Disease

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Effects of Blocking TSLP on Airway Inflammation and the Epithelial Immune-response to Exacerbation Triggers in Patients With COPD
Tezepelumab, Placebo - COPD, COPD Exacerbation
Phase 2UnknownAsger Sverrild802022-10-252024-08-21
Determining Airway pH by Compartmental Exhaled Nitric Oxide Levels During Alkaline Buffer Challenge
Alkaline glycine - Airway Disease
Phase 2Enrolling by invitationIndiana University1502020-09-112025-12-09

Narrower conditions

Immune System Diseases (1)  ·  Pulmonary Disease, Chronic Obstructive (1)

Broader conditions

Chronic Disease (1)  ·  Disease Attributes (1)  ·  Lung Diseases (1)  ·  Lung Diseases, Obstructive (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Respiratory Tract Diseases (1)

Interventions

Optate (1)  ·  tezepelumab (1)

Sponsors

Asger Sverrild (1)  ·  Indiana University (1)

Countries

Denmark (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Asger Sverrild, MD, PhD (1)